Roche Secures FDA Approval for First PTEN-Loss Companion Diagnostic in Prostate Cancer

Roche Diagnostics announced that the U.S. Food and Drug Administration has cleared its VENTANA PTEN (SP218) RxDx Assay, ...

Read story →